P53-regulated networks of protein, mRNA, miRNA, and lncRNA expression revealed by integrated pulsed stable isotope labeling with amino acids in cell culture (pSILAC) and next generation sequencing (NGS) analyses

Molecular and Cellular Proteomics

Volumn 14, Issue 10, 2015, Pages 2609-2629

  Hünten, Sabine ^a   Kaller, Markus ^a   Drepper, Friedel ^c   Oeljeklaus, Silke ^c   Bonfert, Thomas ^a   Erhard, Florian ^a   Dueck, Anne ^d   Eichner, Norbert ^d   Friedel, Caroline C ^a   Meister, Gunter ^d   Zimmer, Ralf ^a   Warscheid, Bettina ^c   Hermeking, Heiko ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; HIGH MOBILITY GROUP B1 PROTEIN; KLF12 PROTEIN; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 192; MICRORNA 200; MICRORNA 200C; MICRORNA 205; MICRORNA 221; MICRORNA 34A; PROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; REPLICATION FACTOR C; STABLE ISOTOPE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; ARGININE; CARBON; DNA; LYSINE; NITROGEN;

3' UNTRANSLATED REGION; AMINO ACID ANALYSIS; ARTICLE; BINDING SITE; BREAST CANCER; CANCER INHIBITION; CANCER SURVIVAL; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHROMATIN IMMUNOPRECIPITATION; CITRIC ACID CYCLE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; DNA REPLICATION; DOWN REGULATION; GENE CONTROL; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG CANCER; METASTASIS FREE SURVIVAL; NEXT GENERATION SEQUENCING; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PULSED STABLE ISOTOPE LABELING WITH AMINO ACIDS IN CELL CULTURE; STOMACH CANCER; TRANSCRIPTION INITIATION SITE; TUMOR GROWTH; UPREGULATION; WNT SIGNALING PATHWAY; DNA SEQUENCE; GENETICS; METABOLISM; TUMOR CELL LINE;

ARGININE; CARBON ISOTOPES; CELL LINE, TUMOR; DNA; HUMANS; ISOTOPE LABELING; LYSINE; MICRORNAS; NITROGEN ISOTOPES; RNA, LONG NONCODING; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84942940170     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.050237     Document Type: Article

References (142)

1. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
2. Hermeking, H. (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 12, 613-626
3. Rokavec, M., Li, H., Jiang, L., and Hermeking, H. (2014) The p53/ microRNA connection in gastrointestinal cancer. Clin. Exp. Gastroenterol. 7, 395-413
4. Vousden, K. H., and Prives, C. (2009) Blinded by the light: The growing complexity of p53. Cell 137, 413-431
5. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991) p53 mutations in human cancers. Science 253, 49-53
6. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainaut, P. (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19, 607-614
7. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. 4, 793-805
8. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49
9. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871
10. Laptenko, O., and Prives, C. (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Different. 13, 951-961
11. Rinn, J. L., and Huarte, M. (2011) To repress or not to repress: this is the guardian's question. Trends Cell Biol. 21, 344-353
12. Wang, B., Xiao, Z., Ko, H. L., and Ren, E. C. (2010) The p53 response element and transcriptional repression. Cell Cycle 9, 870-879
13. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., and Murphy, M. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247-3257
14. Tokino, T., Thiagalingam, S., el-Deiry, W. S., Waldman, T., Kinzler, K. W., and Vogelstein, B. (1994) p53 tagged sites from human genomic DNA. Human Mol. Gen. 3, 1537-1542
15. Nikulenkov, F., Spinnler, C., Li, H., Tonelli, C., Shi, Y., Turunen, M., Kivioja, T., Ignatiev, I., Kel, A., Taipale, J., and Selivanova, G. (2012) Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Different. 19, 1992-2002
16. Dimri, G. P., Nakanishi, M., Desprez, P. Y., Smith, J. R., and Campisi, J. (1996) Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16, 2987-2997
17. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K., and Mo, Y. Y. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U.S.A. 106, 3207-3212
18. Ho, J. S., Ma, W., Mao, D. Y., and Benchimol, S. (2005) p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell. Biol. 25, 7423-7431
19. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
20. Pillai, R. S., Bhattacharyya, S. N., and Filipowicz, W. (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17, 118-126
21. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Gen. Res. 19, 92-105
22. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., and Hermeking, H. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593
23. Chang, T. C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., Arking, D. E., Beer, M. A., Maitra, A., and Mendell, J. T. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752
24. He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A. L., Linsley, P. S., Chen, C., Lowe, S. W., Cleary, M. A., and Hannon, G. J. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134
25. Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., MacDougald, O. A., Cho, K. R., and Fearon, E. R. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307
26. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., and Oren, M. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743
27. Hermeking, H. (2010) The miR-34 family in cancer and apoptosis. Cell Death Different. 17, 193-199
28. Kaller, M., Liffers, S. T., Oeljeklaus, S., Kuhlmann, K., Roh, S., Hoffmann, R., Warscheid, B., and Hermeking, H. (2011) Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol. Cell. Proteomics 10, M111 010462
29. Siemens, H., Jackstadt, R., Hunten, S., Kaller, M., Menssen, A., Gotz, U., and Hermeking, H. (2011) miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271
30. Kim, N. H., Kim, H. S., Li, X. Y., Lee, I., Choi, H. S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., Rowe, R. G., Lee, S., Maher, C. A., Weiss, S. J., and Yook, J. I. (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 195, 417-433
31. Hahn, S., Jackstadt, R., Siemens, H., Hunten, S., and Hermeking, H. (2013) SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J. 32, 3079-3095
32. Rokavec, M., Oner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., and Hermeking, H. (2014) IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 124, 1853-1867
33. Hunten, S., Siemens, H., Kaller, M., and Hermeking, H. (2013) The p53/ microRNA network in cancer: experimental and bioinformatics approaches. Adv. Exp. Med. Biol. 774, 77-101
34. Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., and Miyazono, K. (2009) Modulation of microRNA processing by p53. Nature 460, 529-533
35. Selbach, M., Schwanhausser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63
36. Schwanhausser, B., Gossen, M., Dittmar, G., and Selbach, M. (2009) Global analysis of cellular protein translation by pulsed SILAC. Proteomics 9, 205-209
37. Jackstadt, R., Roh, S., Neumann, J., Jung, P., Hoffmann, R., Horst, D., Berens, C., Bornkamm, G. W., Kirchner, T., Menssen, A., and Hermeking, H. (2013) AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J. Exp. Med. 210, 1331-1350
38. Menssen, A., and Hermeking, H. (2002) Characterization of the c-MYCregulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. U.S.A. 99, 6274-6279
39. Siemens, H., Jackstadt, R., Kaller, M., and Hermeking, H. (2013) Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 4, 1399-1415
40. Welch, C., Chen, Y., and Stallings, R. L. (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022
41. Dueck, A., Eichner, A., Sixt, M., and Meister, G. (2014) A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation. FEBS letters 588, 632-640
42. Ho, C. K., and Shuman, S. (2002) Bacteriophage T4 RNA ligase 2 (gp24.1) exemplifies a family of RNA ligases found in all phylogenetic domains. Proc. Natl. Acad. Sci. U.S.A. 99, 12709-12714
43. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Gen. Biol. 10, R25
44. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J. (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144
45. Windhager, L., Bonfert, T., Burger, K., Ruzsics, Z., Krebs, S., Kaufmann, S., Malterer, G., L'Hernault, A., Schilhabel, M., Schreiber, S., Rosenstiel, P., Zimmer, R., Eick, D., Friedel, C. C., and Dolken, L. (2012) Ultrashort and progressive 4sU-tagging reveals key characteristics of RNA processing at nucleotide resolution. Genome Res. 22, 2031-2042
46. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., and Wold, B. (2008) Mapping and quantifying mammalian transcriptomes by RNASeq. Nat. Meth. 5, 621-628
47. Amati, B., Frank, S. R., Donjerkovic, D., and Taubert, S. (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta 1471, M135-M145
48. Feng, J., Liu, T., and Zhang, Y. (2011) Using MACS to identify peaks from ChIP-Seq data. Curr. Protocols Bioinformatics Chapter 2, Unit 2 14
49. Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., and Noble, W. S. (2009) MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208
50. Whitington, T., Frith, M. C., Johnson, J., and Bailey, T. L. (2011) Inferring transcription factor complexes from ChIP-seq data. Nucleic Acids Res. 39, e98
51. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W. W., and Lenhard, B. (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94
52. Cristodero, M., Mani, J., Oeljeklaus, S., Aeberhard, L., Hashimi, H., Ramrath, D. J., Lukes, J., Warscheid, B., and Schneider, A. (2013) Mitochondrial translation factors of Trypanosoma brucei: elongation factor-Tu has a unique subdomain that is essential for its function. Mol. Microbiol. 90, 744-755
53. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat. Biotechnol. 26, 1367-1372
54. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805
55. UniProt, C. (2014) Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42, D191-D198
56. Vizcaino, J. A., Deutsch, E. W., Wang, R., Csordas, A., Reisinger, F., Rios, D., Dianes, J. A., Sun, Z., Farrah, T., Bandeira, N., Binz, P. A., Xenarios, I., Eisenacher, M., Mayer, G., Gatto, L., Campos, A., Chalkley, R. J., Kraus, H. J., Albar, J. P., Martinez-Bartolome, S., Apweiler, R., Omenn, G. S., Martens, L., Jones, A. R., and Hermjakob, H. (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226
57. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A. M. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6
58. Goswami, C. P., and Nakshatri, H. (2013) PROGgene: gene expression based survival analysis web application for multiple cancers. J. Clin. Bioinformatics 3, 22
59. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P., and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105
60. Krek, A., Grun, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., and Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500
61. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 4, 44-57
62. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
63. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., and Haussler, D. (2002) The human genome browser at UCSC. Gen. Res. 12, 996-1006
64. Cancer Genome Atlas, N. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337
65. Maire, V., Baldeyron, C., Richardson, M., Tesson, B., Vincent-Salomon, A., Gravier, E., Marty-Prouvost, B., De Koning, L., Rigaill, G., Dumont, A., Gentien, D., Barillot, E., Roman-Roman, S., Depil, S., Cruzalegui, F., Pierre, A., Tucker, G. C., and Dubois, T. (2013) TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. PloS one 8, e63712
66. Ambrosini, G., Adida, C., and Altieri, D. C. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921
67. Liu, P., Kao, T. P., and Huang, H. (2008) CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27, 4733-4744
68. Yu, H. (2007) Cdc20: a WD40 activator for a cell cycle degradation machine. Mol. Cell 27, 3-16
69. Yu, M., Zhan, Q., and Finn, O. J. (2002) Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53. Mol. Immunol. 38, 981-987
70. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. 9, 402-412
71. Piovan, C., Palmieri, D., Di Leva, G., Braccioli, L., Casalini, P., Nuovo, G., Tortoreto, M., Sasso, M., Plantamura, I., Triulzi, T., Taccioli, C., Tagliabue, E., Iorio, M. V., and Croce, C. M. (2012) Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol. Oncol. 6, 458-472
72. Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y. J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S. S., Alder, H., Liu, C. G., Dejean, A., and Croce, C. M. (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883
73. Braun, C. J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U. M., Schepeler, T., Orntoft, T. F., Andersen, C. L., and Dobbelstein, M. (2008) p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68, 10094-10104
74. Georges, S. A., Biery, M. C., Kim, S. Y., Schelter, J. M., Guo, J., Chang, A. N., Jackson, A. L., Carleton, M. O., Linsley, P. S., Cleary, M. A., and Chau, B. N. (2008) Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res. 68, 10105-10112
75. Wang, J., Tian, X., Han, R., Zhang, X., Wang, X., Shen, H., Xue, L., Liu, Y., Yan, X., Shen, J., Mannoor, K., Deepak, J., Donahue, J. M., Stass, S. A., Xing, L., and Jiang, F. (2014) Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 33, 1181-1189
76. Chen, L., Lu, M. H., Zhang, D., Hao, N. B., Fan, Y. H., Wu, Y. Y., Wang, S. M., Xie, R., Fang, D. C., Zhang, H., Hu, C. J., and Yang, S. M. (2014) miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis. 5, e1034
77. Gao, X., and Jin, W. (2014) The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett. 353, 25-31
78. Li, M., Guan, X., Sun, Y., Mi, J., Shu, X., Liu, F., and Li, C. (2014) miR-92a family and their target genes in tumorigenesis and metastasis. Exp. Cell Res. 323, 1-6
79. Hwang, M. S., Yu, N., Stinson, S. Y., Yue, P., Newman, R. J., Allan, B. B., and Dornan, D. (2013) miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PloS one 8, e66502
80. Menendez, D., Nguyen, T. A., Freudenberg, J. M., Mathew, V. J., Anderson, C. W., Jothi, R., and Resnick, M. A. (2013) Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res. 41, 7286-7301
81. Idogawa, M., Ohashi, T., Sasaki, Y., Maruyama, R., Kashima, L., Suzuki, H., and Tokino, T. (2014) Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genomewide analysis of p53-binding sites. Human Mol. Gen. 23, 2847-2857
82. Takei, Y., Ishikawa, S., Tokino, T., Muto, T., and Nakamura, Y. (1998) Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system. Genes, Chrom. Cancer 23, 1-9
83. Chien, C. H., Sun, Y. M., Chang, W. C., Chiang-Hsieh, P. Y., Lee, T. Y., Tsai, W. C., Horng, J. T., Tsou, A. P., and Huang, H. D. (2011) Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 39, 9345-9356
84. Chang, G. S., Chen, X. A., Park, B., Rhee, H. S., Li, P., Han, K. H., Mishra, T., Chan-Salis, K. Y., Li, Y., Hardison, R. C., Wang, Y., and Pugh, B. F. (2014) A comprehensive and high-resolution genome-wide response of p53 to stress. Cell Reports 8, 514-527
85. Schlereth, K., Heyl, C., Krampitz, A. M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., and Stiewe, T. (2013) Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Gen. 9, e1003726
86. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005) Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550
87. Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdottir, H., Tamayo, P., and Mesirov, J. P. (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739-1740
88. Tazawa, H., Tsuchiya, N., Izumiya, M., and Nakagama, H. (2007) Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104, 15472-15477
89. Pulikkan, J. A., Peramangalam, P. S., Dengler, V., Ho, P. A., Preudhomme, C., Meshinchi, S., Christopeit, M., Nibourel, O., Muller-Tidow, C., Bohlander, S. K., Tenen, D. G., and Behre, G. (2010) C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116, 5638-5649
90. Zauli, G., Voltan, R., di Iasio, M. G., Bosco, R., Melloni, E., Sana, M. E., and Secchiero, P. (2011) miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin. Cancer Res. 17, 2712-2724
91. Barsotti, A. M., Beckerman, R., Laptenko, O., Huppi, K., Caplen, N. J., and Prives, C. (2012) p53-Dependent induction of PVT1 and miR-1204. J. Biol. Chem. 287, 2509-2519
92. Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R. S., and Nevins, J. R. (1998) E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes & development 12, 2120-2130
93. Ohtani, K., Iwanaga, R., Nakamura, M., Ikeda, M., Yabuta, N., Tsuruga, H., and Nojima, H. (1999) Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18, 2299-2309
94. Tsuruga, H., Yabuta, N., Hosoya, S., Tamura, K., Endo, Y., and Nojima, H. (1997) HsMCM6: a new member of the human MCM/P1 family encodes a protein homologous to fission yeast Mis5. Genes Cells 2, 381-399
95. Alon, U. (2007) Network motifs: theory and experimental approaches. Nat. Rev. Genetics 8, 450-461
96. Liu, K., Huang, J., Xie, M., Yu, Y., Zhu, S., Kang, R., Cao, L., Tang, D., and Duan, X. (2014) miR-34a regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy 10, 442-452
97. Botcheva, K., McCorkle, S. R., McCombie, W. R., Dunn, J. J., and Anderson, C. W. (2011) Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle 10, 4237-4249
98. Wei, C. L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Liu, J., Zhao, X. D., Chew, J. L., Lee, Y. L., Kuznetsov, V. A., Sung, W. K., Miller, L. D., Lim, B., Liu, E. T., Yu, Q., Ng, H. H., and Ruan, Y. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124, 207-219
99. Fischer, M., Steiner, L., and Engeland, K. (2014) The transcription factor p53: not a repressor, solely an activator. Cell Cycle 13, 3037-3058
100. Li, M., He, Y., Dubois, W., Wu, X., Shi, J., and Huang, J. (2012) Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Molecular Cell 46, 30-42
101. Zheng, R., and Blobel, G. A. (2010) GATA Transcription Factors and Cancer. Genes Cancer 1, 1178-1188
102. Bartunek, P., Kralova, J., Blendinger, G., Dvorak, M., and Zenke, M. (2003) GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 22, 1927-1935
103. Munugalavadla, V., Dore, L. C., Tan, B. L., Hong, L., Vishnu, M., Weiss, M. J., and Kapur, R. (2005) Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation. Mol. Cell. Biol. 25, 6747-6759
104. Rylski, M., Welch, J. J., Chen, Y. Y., Letting, D. L., Diehl, J. A., Chodosh, L. A., Blobel, G. A., and Weiss, M. J. (2003) GATA-1-mediated proliferation arrest during erythroid maturation. Mol. Cell. Biol. 23, 5031-5042
105. Trainor, C. D., Mas, C., Archambault, P., Di Lello, P., and Omichinski, J. G. (2009) GATA-1 associates with and inhibits p53. Blood 114, 165-173
106. Gregory, T., Yu, C., Ma, A., Orkin, S. H., Blobel, G. A., and Weiss, M. J. (1999) GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94, 87-96
107. Yan, W., Cao, Q. J., Arenas, R. B., Bentley, B., and Shao, R. (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelialmesenchymal transition. J. Biol. Chem. 285, 14042-14051
108. van Hamburg, J. P., de Bruijn, M. J., Dingjan, G. M., Beverloo, H. B., Diepstraten, H., Ling, K. W., and Hendriks, R. W. (2008) Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes. Mol. Immunol. 45, 3085-3095
109. Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., and Vogelstein, B. (1999) Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. U.S.A. 96, 14517-14522
110. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., and Levine, A. J. (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Develop. 14, 981-993
111. Oh, H. K., Tan, A. L., Das, K., Ooi, C. H., Deng, N. T., Tan, I. B., Beillard, E., Lee, J., Ramnarayanan, K., Rha, S. Y., Palanisamy, N., Voorhoeve, P. M., and Tan, P. (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin. Cancer Res. 17, 2657-2667
112. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T., and Rinn, J. L. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419
113. Huarte, M., and Rinn, J. L. (2010) Large non-coding RNAs: missing links in cancer? Human Mol. Gen. 19, R152-R161
114. Sanchez, Y., Segura, V., Marin-Bejar, O., Athie, A., Marchese, F. P., Gonzalez, J., Bujanda, L., Guo, S., Matheu, A., and Huarte, M. (2014) Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat. Commun. 5, 5812
115. Prensner, J. R., and Chinnaiyan, A. M. (2011) The emergence of lncRNAs in cancer biology. Cancer Discovery 1, 391-407
116. Gibb, E. A., Brown, C. J., and Lam, W. L. (2011) The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 10, 38
117. Lee, G. L., Dobi, A., and Srivastava, S. (2011) Prostate cancer: diagnostic performance of the PCA3 urine test. Nature reviews. Urology 8, 123-124
118. Tomlins, S. A., Aubin, S. M., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., Penabella, Y., Day, J. R., Varambally, R., Han, B., Wood, D., Wang, L., Sanda, M. G., Rubin, M. A., Rhodes, D. R., Hollenbeck, B., Sakamoto, K., Silberstein, J. L., Fradet, Y., Amberson, J. B., Meyers, S., Palanisamy, N., Rittenhouse, H., Wei, J. T., Groskopf, J., and Chinnaiyan, A. M. (2011) Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci. Transl. Med. 3, 94ra72
119. Fu, Y., Huang, J., Wang, K. S., Zhang, X., and Han, Z. G. (2011) RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells. Mol. Biol. Rep. 38, 693-702
120. Whitworth, H., Bhadel, S., Ivey, M., Conaway, M., Spencer, A., Hernan, R., Holemon, H., and Gioeli, D. (2012) Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen. PloS one 7, e38950
121. Ehrlichova, M., Mohelnikova-Duchonova, B., Hrdy, J., Brynychova, V., Mrhalova, M., Kodet, R., Rob, L., Pluta, M., Gut, I., Soucek, P., and Vaclavikova, R. (2013) The association of taxane resistance genes with the clinical course of ovarian carcinoma. Genomics 102, 96-101
122. Xing, Z., Lin, A., Li, C., Liang, K., Wang, S., Liu, Y., Park, P. K., Qin, L., Wei, Y., Hawke, D. H., Hung, M. C., Lin, C., and Yang, L. (2014) lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 159, 1110-1125
123. Merkel, A. L., Meggers, E., and Ocker, M. (2012) PIM1 kinase as a target for cancer therapy. Expert Opin. Invest. Drugs 21, 425-436
124. Tang, D., Kang, R., Zeh, H. J., 3rd, and Lotze, M. T. (2010) High-mobility group box 1 and cancer. Biochim. Biophys. Acta 1799, 131-140
125. Kang, R., Zhang, Q., Zeh, H. J., 3rd, Lotze, M. T., and Tang, D. (2013) HMGB1 in cancer: good, bad, or both? Clin. Cancer Res. 19, 4046-4057
126. Lotze, M. T., and DeMarco, R. A. (2003) Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4, 1405-1409
127. Uramoto, H., Izumi, H., Nagatani, G., Ohmori, H., Nagasue, N., Ise, T., Yoshida, T., Yasumoto, K., and Kohno, K. (2003) Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. Biochem. J. 371, 301-310
128. Livesey, K. M., Kang, R., Vernon, P., Buchser, W., Loughran, P., Watkins, S. C., Zhang, L., Manfredi, J. J., Zeh, H. J., 3rd, Li, L., Lotze, M. T., and Tang, D. (2012) p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 72, 1996-2005
129. Livesey, K. M., Tang, D., Zeh, H. J., and Lotze, M. T. (2009) Autophagy inhibition in combination cancer treatment. Curr. Opin. Investig. Drugs 10, 1269-1279
130. Chang, B. P., Wang, D. S., Xing, J. W., Yang, S. H., Chu, Q., and Yu, S. Y. (2014) miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1. J. Huazhong Univ. Sci. Technolog. Med. Sci. 34, 201-206
131. Nakamura, Y., Migita, T., Hosoda, F., Okada, N., Gotoh, M., Arai, Y., Fukushima, M., Ohki, M., Miyata, S., Takeuchi, K., Imoto, I., Katai, H., Yamaguchi, T., Inazawa, J., Hirohashi, S., Ishikawa, Y., and Shibata, T. (2009) Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int. J. Cancer 125, 1859-1867
132. Fearon, E. R., and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759-767
133. Chen, Y., Zhu, X., Zhang, X., Liu, B., and Huang, L. (2010) Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 18, 1650-1656
134. Pramanik, D., Campbell, N. R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J. T., and Maitra, A. (2011) Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480
135. Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., and Bader, A. G. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70, 5923-5930
136. Bader, A. G. (2012) miR-34-a microRNA replacement therapy is headed to the clinic. Front. Gen. 3, 120
137. Gu, S., Liu, Z., Pan, S., Jiang, Z., Lu, H., Amit, O., Bradbury, E. M., Hu, C. A., and Chen, X. (2004) Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol. Cell. Proteomics 3, 998-1008
138. Jenkins, L. M., Mazur, S. J., Rossi, M., Gaidarenko, O., Xu, Y., and Appella, E. (2008) Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes. Mol. Cell. Proteomics 7, 716-727
139. Nicholson, J., Neelagandan, K., Huart, A. S., Ball, K., Molloy, M. P., and Hupp, T. (2012) An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasis. J. Proteome Res. 11, 5464-5478
140. Tay, Y., Rinn, J., and Pandolfi, P. P. (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344-352
141. Kel, A. E., Kel-Margoulis, O. V., Farnham, P. J., Bartley, S. M., Wingender, E., and Zhang, M. Q. (2001) Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J. Mol. Biol. 309, 99-120
142. Ma, Y., Croxton, R., Moorer, R. L., Jr., and Cress, W. D. (2002) Identification of novel E2F1-regulated genes by microarray. Arch. Biochem. Biophys. 399, 212-224